Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 5 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors at 5 institutions in 4 countries.
Kit-Kay MakDepartment of Pharmaceutical Chemistry, School of Pharmacy, International Medical University, Kuala Lumpur 57000, Malaysia.ORCID 0000-0001-6939-5280
Zhang ShimingSchool of Postgraduate Studies, International Medical University, Kuala Lumpur 57000, Malaysia.
Jun Sheng LowSchool of Postgraduate Studies, International Medical University, Kuala Lumpur 57000, Malaysia.ORCID 0000-0003-1142-9593
Madhu Katyayani BalijepalliDepartment of Pharmacology, Faculty of Medicine, MAHSA University, Jenjarom 42610, Malaysia.
Raghavendra SakirollaDepartment of Chemistry, Central University of Karnataka, Gulbarga 585367, India.
Albena T Dinkova-KostovaJacqui Wood Cancer Centre, Division of Cellular Medicine, School of Medicine, University of Dundee, Dundee DD1 4HN, UK.ORCID 0000-0003-0316-9859
Ola EpemoluCharles River Laboratories Edinburgh Ltd., Tranent EH33 2NE, UK.
Zulkefeli MohdDepartment of Pharmaceutical Chemistry, School of Pharmacy, International Medical University, Kuala Lumpur 57000, Malaysia.
Mallikarjuna Rao PichikaDepartment of Pharmaceutical Chemistry, School of Pharmacy, International Medical University, Kuala Lumpur 57000, Malaysia.
IMU University · MYCentral University of Karnataka · INCharles River Laboratories (United Kingdom) · GBJohns Hopkins University · USMahsa University · MY
Funding
International Medical University PMHS I-2018 (02)Ministry of Higher Education FRGS/1/2018/WAB13/MAHSA/02/1
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Anti-Inflammatory Effects of Auranamide and Patriscabratine-Mechanisms and In Silico Studies. · full record | OpenQuestion